KEGG   DRUG: Vixarelimab
Entry
D11800                      Drug                                   
Name
Vixarelimab (USAN)
Formula
C6416H9906N1700O2037S48
Exact mass
144897.0411
Mol weight
144986.68
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYEINWVRQA TGQGLEWMGW MNPNSGYTGY
AQKFQGRVTM TRDTSISTAY MEMSSLRSED TAVYYCARDI VAANTDYYFY YGMDVWGQGT
TVTVSSASTK GPSVFPLAPC SRSTSESTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
AVLQSSGLYS LSSVVTVPSS SLGTKTYTCN VDHKPSNTKV DKRVESKYGP PCPPCPAPEF
LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSQEDPEVQ FNWYVDGVEV HNAKTKPREE
QFQSTYRVVS VLTVLHQDWL NGKEYKCKVS NKGLPSSIEK TISKAKGQPR EPQVYTLPPS
RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK
SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PG
(Light chain)
QSVLTQPPSA SGTPGQRVTI SCSGSNSNIG SNTVNWYHQL PGTAPKLLIY NINKRPSGVP
DRFSGSKSGS SASLAISGLQ SEDEADYYCS TWDDSLDGVV FGGGTKLTVL GQPKAAPSVT
LFPPSSEELQ ANKATLVCLI SDFYPGAVTV AWKADSSPVK AGVETTTPSK QSNNKYAASS
YLSLTPEQWK SHRSYSCQVT HEGSTVEKTV APTECS
(Disulfide bridge: H22-H96, H140-L215, H153-H209, H232-H'232, H235-H'235, H267-H327, H373-H431, H'22-H'96, H'140-L'215, H'153-H'209, H'267-H'327, H373-H'431, L22-L89, L138-L197, L'22-L'89, L'138-L'197)
  Type
Peptide
Efficacy
Antipruritic, Anti-oncostatin M receptor antibody
  Type
Monoclonal antibody
Comment
Treatment of chronic pruritic diseases
Target
OSMR [HSA:9180] [KO:K05057]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04151  PI3K-Akt signaling pathway
hsa04630  JAK-STAT signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Interleukin receptors
    OSMR
     D11800  Vixarelimab (USAN)
Other DBs
CAS: 2243320-83-2
PubChem: 405226666
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system